Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eurofins Viracor BioPharma is a premier clinical research organization (CRO) specializing in high-complexity specialty testing for the biopharmaceutical industry. The company provides a comprehensive suite of services including bioanalytical testing, biomarker development, and immunogenicity assays to support all phases of clinical development. With a core focus on immunology, infectious diseases, and transplant medicine, Eurofins Viracor leverages advanced technologies such as qPCR, flow cytometry, and NGS. Their expertise helps drug developers navigate complex regulatory requirements and accelerate the timeline for bringing novel therapies to market. The company operates out of state-of-the-art, CLIA-certified and CAP-accredited laboratory facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eurofins Viracor BioPharma.